首页|期刊导航|中国体外生命支持|冠脉介入患者术中接受静脉-动脉体外膜氧合联合主动脉内球囊反搏支持的疗效分析

冠脉介入患者术中接受静脉-动脉体外膜氧合联合主动脉内球囊反搏支持的疗效分析OA

Clinical Efficacy of Veno-Arterial Extracorporeal Membrane Oxygenation Combined With Intra-Aortic Balloon Pump Support in Patients Undergoing Percutaneous Coronary Intervention

中文摘要英文摘要

目的 探讨在冠脉介入术(PCI)过程中突发急性血流动力学不稳定状态下,应用静脉-动脉体外膜氧合(V-A ECMO)联合主动脉内球囊反搏(IABP)支持的临床疗效及其对短期预后的影响.方法 采用回顾性队列研究方法,纳入2020年1月至2024年12月于本院接受择期或急诊PCI过程中突发血流动力学不稳定并给予机械循环支持的患者共73例,根据机械支持模式分为ECMO联合IABP组(联合组,n=28)与单纯IABP组(对照组,n=45).收集患者一般资料、PCI相关参数、术中最低平均动脉压(MAP)、乳酸水平、心率、术后24 h血气指标(pH、动脉氧分压、乳酸)、ICU停留时间、撤机率、并发症发生率及28 d生存率等.采用t检验、χ2检验、Logistic回归、Kaplan-Meier生存分析及受试者工作特征(ROC)曲线评估干预效果及预后相关因素.结果 两组患者术前基线资料差异无统计学意义(均P>0.05).联合组术中最低MAP为(54.37±7.12)mmHg,显著低于对照组(61.09±6.38)mmHg(P=0.002);术后1 h乳酸水平为(5.94±1.83)mmol/L,高于对照组(4.27±1.58)mmol/L(P=0.008),但干预6 h后乳酸下降幅度更大(-2.12±0.94)mmol/L vs.(-1.18±0.88)mmol/L,P=0.004).联合组28 d生存率为75.00%,高于对照组57.78%(P=0.048).单因素Logistic回归分析提示,干预方式、术后6 h乳酸、术后24 h pH值、Killip分级及术中最低MAP为可能影响生存的相关因素(均P<0.05);多因素Logistic回归结果显示,V-A ECMO联合IABP干预(OR=0.30,95%CI:0.10~0.89,P=0.030)及术后6 h乳酸浓度(OR=1.51,95%CI:1.10~2.08,P=0.012)为28 d死亡的独立预测因素.ROC曲线显示,术后6 h乳酸预测28 d死亡的曲线下面积为0.812(95%CI:0.716~0.908,P<0.001),最佳截断值为4.63 mmol/L,敏感度为84.21%,特异度为73.81%.结论 对于PCI术中突发急性血流动力学不稳定的高危患者,V-A ECMO联合IABP支持可在早期稳定循环状态、加速代谢产物清除并提高短期生存率.术后6 h乳酸水平可作为良好的早期死亡风险预测指标,提示该策略在急危重PCI人群中具有重要的临床应用价值.

Objective To evaluate the clinical efficacy and short-term prognosis impact of veno-arterial extracorporeal membrane oxygenation(V-A ECMO)combined with intra-aortic balloon pump(IABP)support in patients experiencing acute hemodynamic instability during percutaneous coronary intervention(PCI).Methods A retrospective cohort study was conducted,including 73 patients who received mechanical circulatory support due to sudden hemodynamic deterioration during elective or emergency PCI and at our center from January 2020 to December 2024.Patients were categorized into two groups based on the support modality:the combination group(V-A ECMO+IABP,n=28)and the IABP-only group(n=45).Baseline characteristics,PCI-related parameters,intraoperative lowest mean arterial pressure(MAP),lactate levels,heart rate,postoperative 24-hour arterial blood gas parameters(pH,PaO2,lactate),ICU stay duration,weaning success rate,complication rates,and 28-day survival were collected and compared.Student's t-test,χ2 test,logistic regression,Kaplan-Meier survival analysis,and receiver operating characteristic(ROC)curve were employed to evaluate intervention efficacy and prognostic factors.Results No significant differences were observed in baseline characteristics between the two groups(all P>0.05).The combination group had a significantly lower intraoperative MAP compared to the control group(54.37±7.12 mmHg vs.61.09±6.38 mmHg,P=0.002),and a higher lactate level at 1 hour post-procedure(5.94±1.83 vs.4.27±1.58 mmol/L,P=0.008).However,the 6-hour lactate clearance was significantly greater in the combination group(-2.12±0.94 vs.-1.18±0.88 mmol/L,P=0.004).The 28-day survival rate was higher in the combination group(75.00%)than in the IABP-only group(57.78%,P=0.048).Univariate logistic regression analysis identified treatment modality,6-hour lactate level,24-hour pH,Killip class,and intraoperative MAP as potential predictors of 28-day mortality(all P<0.05).Multivariate analysis confirmed that combined V-A ECMO+IABP support(OR=0.30,95%CI:0.10-0.89,P=0.030)and 6-hour lactate level(OR=1.51,95%CI:1.10-2.08,P=0.012)were independent predictors of 28-day mortality.ROC analysis demonstrated that 6-hour lactate level had good predictive value for 28-day mortality,with an AUC of 0.812(95%CI:0.716-0.908,P<0.001),an optimal cut-off of 4.63 mmol/L,sensitivity of 84.21%,and specificity of 73.81%.Conclusion For high-risk patients experiencing acute hemodynamic instability during PCI,V-A ECMO combined with IABP support provides superior early circulatory stabilization,facilitates more effective lactate clearance,and improves short-term survival compared to IABP alone.The 6-hour post-procedural lactate level serves as a valuable early predictor of mortality,highlighting the clinical significance of this combined strategy in critically ill PCI populations.

徐陶锐;岳渊渊;员旭红;王家璞

山西省心血管病医院,山西省心血管病研究所,山西医科大学附属心血管病医院心内科,太原 030024山西省心血管病医院,山西省心血管病研究所,山西医科大学附属心血管病医院心内科,太原 030024山西省心血管病医院,山西省心血管病研究所,山西医科大学附属心血管病医院心内科,太原 030024山西省心血管病医院,山西省心血管病研究所,山西医科大学附属心血管病医院心内科,太原 030024

冠脉介入体外膜氧合主动脉内球囊反搏预后乳酸生存分析

percutaneous coronary interventionextracorporeal membrane oxygenationintra-aortic balloon pumpprognosislactatesurvival analysis

《中国体外生命支持》 2026 (2)

132-138,7

10.13498/j.cnki.chin.j.ecls.2026.02.09

评论